Valuation: Samsung Biologics Co.,Ltd.

Market Cap 64,020B 42.97B 37.57B 34.66B 31.86B 60.37B 4,135B 61.4B 414B 162B 2,021B 161B 158B 6,966B P/E 2026 *
34.2x
P/E 2027 * 28.9x
Enterprise Value 62.54B 41.98M 36.71M 33.86M 31.13M 58.98M 4.04B 59.99M 404M 159M 1.97B 158M 154M 6.81B EV / Sales 2026 *
11.6x
EV / Sales 2027 * 9.7x
Free-Float
25.52%
Yield 2026 *
-
Yield 2027 * -
1 day+1.10%
1 week+38.30%
Current month+38.30%
1 month+38.30%
3 months+38.30%
6 months+38.30%
Current year+38.30%
1 week 1,000,000
Extreme 999999.9999
1,418,000
1 month 1,000,000
Extreme 999999.9999
1,418,000
Current year 1,000,000
Extreme 999999.9999
1,418,000
1 year 1,000,000
Extreme 999999.9999
1,418,000
3 years 1,000,000
Extreme 999999.9999
1,418,000
5 years 1,000,000
Extreme 999999.9999
1,418,000
10 years 192,960.76
Extreme 192960.7607
1,418,000
Manager TitleAgeSince
Chief Executive Officer 64 09/12/2020
Director of Finance/CFO 58 14/03/2025
Chief Operating Officer 50 -
Director TitleAgeSince
Director/Board Member 72 29/03/2022
Director/Board Member 70 15/03/2024
Director/Board Member 67 20/03/2020
Date Insider Type Main position Quantity % Market Cap.
12-11Buy

Director

60 0.0001%
12-03Don

Executive/Senior Manager

400 0.0009%
12-02Free 387 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
+1.10%+38.30%+38.30%+38.30% 42.55B
+1.27%+0.24%+21.26%-7.53% 66.75B
+1.38%-5.23%+38.08%+197.15% 50.65B
+0.62%-2.34%-50.46%-52.64% 41.15B
+2.76%-1.56%+54.70%-29.29% 28.34B
+1.25%-7.48%+116.21%-43.73% 26.76B
+0.18%-1.85%+68.63%+86.35% 22.95B
-3.09%+8.92%+9.11%+198.57% 20B
-1.70%+5.53%+76.00%+353.68% 16.48B
+0.44%-3.68%+55.00%+124.19% 16.3B
Average +0.43%-0.73%+42.68%+86.51% 33.19B
Weighted average by Cap. +0.79%-0.88%+34.55%+62.52%

Financials

2026 *2027 *
Net sales 5,385B 3.61B 3.16B 2.92B 2.68B 5.08B 348B 5.16B 34.8B 13.66B 170B 13.57B 13.28B 586B 6,290B 4.22B 3.69B 3.41B 3.13B 5.93B 406B 6.03B 40.65B 15.95B 199B 15.86B 15.51B 684B
Net income 1,871B 1.26B 1.1B 1.01B 931M 1.76B 121B 1.79B 12.09B 4.74B 59.06B 4.72B 4.61B 204B 2,212B 1.48B 1.3B 1.2B 1.1B 2.09B 143B 2.12B 14.3B 5.61B 69.83B 5.58B 5.45B 241B
Net Debt -1,476B -991M -867M -799M -735M -1.39B -95.36B -1.42B -9.54B -3.74B -46.61B -3.72B -3.64B -161B -2,998B -2.01B -1.76B -1.62B -1.49B -2.83B -194B -2.88B -19.38B -7.6B -94.64B -7.56B -7.39B -326B
Logo Samsung Biologics Co.,Ltd.
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.
Employees
5,195
Date Price Change Volume
15/07/26 ₩1,383,000.00 +1.10% 40,849
14/07/26 ₩1,368,000.00 -2.29% 65,068
13/07/26 ₩1,400,000.00 +0.36% 45,614
10/07/26 ₩1,395,000.00 +5.28% 43,685
09/07/26 ₩1,325,000.00 -2.79% 51,344
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
1,383,000.00KRW
Average target price
2,052,158.80KRW
Spread / Average Target
+48.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A207940 Stock